NEW YORK, September 7 (newratings.com) - Analysts at Robert W Baird upgrade Acorda Therapeutics Inc (ticker: ACOR) from "neutral" to "outperform." The target price is set to $40. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade Cymer (ticker: CYMI) from "overweight" to "equal weight." The target price has been reduced from $42 to $30. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade LTX-Credence (ticker: LTXC) from "overweight" to "equal weight." The target price is set to $4. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Barclays Capital downgrade KLA-Tencor (ticker: KLAC) from "overweight" to "equal weight." The target price has been reduced from $45 to $30. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Werner Enterprises (ticker: WERN) from "hold" to "buy." The target price is set to $28. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Pacer International (ticker: PACR) from "hold" to "buy." The target price is set to $8. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Landstar System (ticker: LSTR) from "hold" to "buy." The target price is set to $51. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Hub Group Inc (ticker: HUBG) from "hold" to "buy." The target price is set to $38. [more]
NEW YORK, September 7 (newratings.com) - Analysts at Stifel Nicolaus & Company upgrade Heartland Express (ticker: HTLD) from "hold" to "buy." The target price is set to $19. [more]
NEW YORK, September 7 (newratings.com) - Analysts at KeyBanc Capital Markets downgrade NiSource (ticker: NI) from "buy" to "hold." [more]